Australia markets closed

SomnoMed Limited (SOM.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2100-0.0050 (-2.33%)
At close: 03:18PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
83,616
83,616
72,580
62,706
57,296
Cost of revenue
31,694
31,694
28,302
24,962
24,197
Gross profit
51,922
51,922
44,279
37,744
33,100
Operating expenses
Research development
5,055
12,236
10,921
7,760
5,055
Selling general and administrative
38,641
38,641
33,553
26,795
25,901
Total operating expenses
55,994
55,994
48,410
38,599
34,041
Operating income or loss
-4,073
-4,073
-4,131
-854.937
-940.984
Interest expense
2,304
2,304
84.033
129.75
166.914
Total other income/expenses net
-347.945
-347.945
1,016
586.269
2,148
Income before tax
-7,045
-7,045
-3,496
-733.899
746.993
Income tax expense
821.637
821.637
930.607
349.162
1,185
Income from continuing operations
-7,867
-7,867
-4,426
-1,083
-438.31
Net income
-7,999
-7,999
-4,437
-1,193
-1,119
Net income available to common shareholders
-7,999
-7,999
-4,437
-1,193
-1,119
Basic EPS
-0.06
-0.10
-0.05
-0.01
-0.02
Diluted EPS
-0.06
-0.10
-0.05
-0.01
-0.02
Basic average shares
82,201
82,149
82,143
82,009
66,019
Diluted average shares
82,201
82,149
82,143
82,009
66,019